ERBB2 and neoplasm: Human epidermal growth factor receptor (HER2)-directed CART cells in 16 patients with HER2-expressing osteosarcomas stabilized the disease for 12 weeks in three patients, and one patient showed 90% tumor necrosis on histological analysis after surgical excision [50].